Nutrition

Protara Therapeutics Announces Dosing of First Patient in Phase 1b/2 ADVANCED-2 Trial of TARA-002 in NMIBC Patients with High Grade Carcinoma in Situ

Dosing is progressing on schedule in ongoing ADVANCED-1EXP trial evaluating TARA-002 in NMIBC patients with CIS; preliminary results expected in...

Cellev8, the First SOD Product Shatters the Mold with NSF Certified for Sport Accreditation, Paving the Way for Unprecedented Cellular Performance Supplements!

AllStar Health & Tyme Cannabis Co Signs a Memorandum of Understanding (MOU) ‘Growing Together to Dominate The Cannabis Market Throughout Ontario Canada’

Miami, Florida--(Newsfile Corp. - September 15, 2023) - AllStar Health Brands Inc. (OTC PINK: ALST) ("AllStar" or "the Company") Memorandum...

CD34 NU-Signals and Alzheimer’s Disease Human Trials Presentation With Tzu Chi Hospital and Beauty-Stem Biomedical, Subsidiary of Power-Stem Biomedical Group

Unveiling the Potential Breakthrough - Activating Stem Cells to Delay and Reduce Dementia and Depression RiskLOS ANGELES, CA / ACCESSWIRE...

error: Content is protected !!